LONG-TERM METABOLIC ASSESSMENTS IN SUBJECTS TREATED WITH EMTRICITABINE/TENOFO

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本研究的目的是了解服用尿苷补充剂 (NucleomaxX¿) 对于 HIV 感染者是否安全，以及是否可以逆转面部、手臂、腿部或臀部脂肪的减少。该研究还将尝试了解 NucleomaxX 的耐受性如何。 NucleomaxX 是一种粉状营养食品补充剂，含有一种称为尿苷的物质。它采用小袋（小包）形式，需要与果汁、牛奶或水混合。 NucleomaxX 在欧洲用作食品补充剂，但未经美国食品和药物管理局 (FDA) 批准，在美国被视为实验药物 全国约有 164 人将参加这项研究。大约有 20 人将在该站点参加。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to see if taking a uridine supplement (NucleomaxX¿) is safe in HIV-infected persons and if it will reverse loss of fat in the face, arms, legs, or buttocks. The study will also try to see how well NucleomaxX is tolerated. NucleomaxX is a powdered nutritional food supplement that contains a substance called uridine. It comes in a sachet (packet) and needs to be mixed in with juice, milk, or water. NucleomaxX is used in Europe as a food supplement but is not approved by the U.S. Food and Drug Administration (FDA) and is considered an experimental drug in the U.S About 164 people will take part in this study across the country. About 20 will take part in it at this site.